GlobalData on MSN

Boston Scientific touts long-term data of SCS therapy

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Medical Device Network

Abbott touts neuromodulation portfolio’s long-term benefits

Abbott has touted the potential of its neuromodulation portfolio in reducing patient and healthcare burdens associated with ...
Business Insider

New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

Evidence Published in Diabetes Research and Clinical Practice Shows 10 kHz Therapy Yields Lasting Pain Relief and Enhances Health-Related Quality of Life and Sleep REDWOOD CITY, Calif., Aug. 16, 2023 ...
Seeking Alpha

New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy

Analysis Marks the First Study of Spinal Cord Stimulation to Demonstrate Long-term, Significant, and Clinically Meaningful Reductions in HbA1c and Weight in Study Participants with Painful Diabetic ...
Nasdaq

Nevro's (NVRO) New Data Supports SCS Therapy for NSRBP Treatment

Nevro Corp. NVRO recently announced the publication of new 24-month data from the SENZA Nonsurgical Refractory Back Pain (NSRBP) multicenter randomized controlled trial (RCT) in the Journal of ...
Medical Xpress

Fast-acting sub-perception therapy spinal cord stimulation found to reduce back pain

Patients with chronic pain treated with the novel Fast-Acting Sub-Perception Therapy (FAST) spinal cord stimulation (SCS) systems may achieve significant and durable pain relief for up to 12 months of ...
Morningstar

New Data Show Significant Pain Relief, Reduced Opioid Use, Decreased Patient Time and Cost Burdens with the ProsperaTM SCS System

24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...
Morningstar

First-of-its-Kind Study Shows Visibility into Real-Time Spinal Cord Stimulation Utilization and Supports a New Standard of Long-Term Device Management

Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use and lower explant rates LAKE OSWEGO, Ore., Jan. 5, 2026 /PRNewswire/ -- A new ...
Business Wire

St. Jude Medical Announces FDA Approval of BurstDR Stimulation, a New Superior Spinal Cord Stimulation Option for Patients Suffering from Chronic Pain

Fortunately, SCS therapy can transform quality of life for many people who are otherwise unable to find relief from chronic pain. BurstDR stimulation from St. Jude Medical has been clinically proven ...
Seeking Alpha

New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

Evidence Published in Diabetes Research and Clinical Practice Shows 10 kHz Therapy Yields Lasting Pain Relief and Enhances Health-Related Quality of Life and Sleep Published 24-month data from the ...
Nasdaq

New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

Evidence Published in Diabetes Research and Clinical Practice Shows 10 kHz Therapy Yields Lasting Pain Relief and Enhances Health-Related Quality of Life and Sleep Globally, the number of people with ...